EFSA Reviews Clodinafop Risk

The European Food Safety Authority has issued its latest peer review on the pesticide risk assessment of clodinafop, reopening attention on one of the familiar truths of modern crop protection regulation: approval is no longer just about whether a substance works in the field. It is about whether the scientific package around it can withstand years of increasingly detailed scrutiny. In this case, EFSA reviewed clodinafop-propargyl as a herbicide for use on wheat, rye and triticale, based on the initial assessments prepared by Greece as rapporteur Member State and Germany as co-rapporteur. The agency said it had identified reliable endpoints suitable for regulatory risk assessment, but it also listed missing information required under the regulatory framework and flagged concerns that remain unresolved.

That combination matters. A substance can still appear agronomically useful while becoming increasingly difficult to defend in the regulatory arena. For companies and growers, that is often where the real tension lies. Clodinafop belongs to a category of crop protection tools valued for practical weed control in cereal production, yet the European system no longer evaluates such products only through a narrow efficacy lens. It now demands a broader scientific confidence covering operator exposure, non-dietary exposure, long-term safety questions, and endocrine-disrupting properties. EFSA’s updated conclusion reflects exactly that wider standard.

One notable element in this review is the European Commission’s request for EFSA to reconsider the acceptable operator exposure level and update the non-dietary exposure assessment if necessary. That is not a minor technical footnote. It indicates that exposure questions remain central to the debate and that regulators are not satisfied with relying solely on older assumptions. When exposure benchmarks are revisited, the practical implications can extend far beyond paperwork. They can affect how a product is handled, whether risk mitigation measures become stricter, and ultimately whether continued approval remains commercially realistic.

The update on endocrine-disrupting properties adds another layer of sensitivity. In Europe, endocrine concerns have become one of the most politically and scientifically consequential issues in pesticide regulation. Once that dimension enters the conversation, the discussion shifts from ordinary renewal mechanics to a much more difficult test of regulatory acceptability. That does not automatically mean clodinafop has no future, but it does mean the burden of proof becomes heavier.

What this review really shows is that European pesticide regulation is now a process of cumulative pressure. A product may face not one decisive problem, but a series of smaller scientific and regulatory demands that together become hard to overcome. For the cereal sector, that creates uncertainty around weed-management options. For regulators, it reflects the ongoing effort to maintain a system built on precaution, scientific review and repeated reassessment. And for the industry, it is another reminder that in Europe, keeping a product on the market often proves harder than bringing it there in the first place.